Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ebru Karcı is active.

Publication


Featured researches published by Ebru Karcı.


Future Oncology | 2018

Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer

Dilsa Mizrak Kaya; Bengi Öztürk; Pinar Kubilay; Handan Onur; Güngör Utkan; Filiz Cay Senler; Ali Alkan; Halis Yerlikaya; Elif Berna Koksoy; Ebru Karcı; Ahmet Demirkazik; Hakan Akbulut; Fikri Icli

AIM There are inconsistent results about the effects of vitamin D level on breast cancer prognosis. We aimed to investigate the effect of vitamin D levels on the prognosis of resectable breast cancer in a patient group with highly different clothing styles. PATIENTS & METHODS A total of 186 breast cancer patients were enrolled in the study. RESULTS Vitamin D level was sufficient, insufficient and deficient in 17.2, 52.2 and 30.6% of patients, respectively. There was a significant relationship between clothing style and serum 25 (OH) D levels. We could not establish any relation between vitamin D level and tumor characteristics or survival. CONCLUSION Vitamin D supplementation can be more important than diagnostic serum vitamin D level on prognosis of breast cancer.


Cancer Investigation | 2017

Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

Cemil Bilir; Ibrahim Yildiz; Ahmet Bilici; Mahmut Ucar; Veli Berk; Yasar Yildiz; Ozan Yazici; Goksen Inanc Imamoglu; Nuri Karadurmuş; Kezban Nur Pilanci; Erkan Arpaci; Ozgur Tanriverdi; Ebru Karcı; Suleyman Temiz; Erdinc Nayir; Esin Oktay; Pınar Dal; İbrahim Petekkaya; Ceyhun Varım; Hakan Cinemre

ABSTRACT Background: There are insufficient predictive markers for renal cell carcinoma (RCC). Methods: A total of 308 metastatic RCC patients were analyzed retrospectively. Results: The increased hemoglobin (Hb) group had significantly higher progression-free survival and overall survival (OS) compared with the decreased Hb group at 11.5 versus 6.35 months (p < .001) and 21.0 versus 11.36 months (p < .001) respectively. The 1- and 3-year OS rates were higher in the Hb increased group, i.e., 84% versus 64% and 52% versus 35% respectively. Conclusions: The present study showed that increased Hb levels after tyrosine kinase inhibitor therapy could be a predictive marker of RCC.


Turkish journal of haematology : official journal of Turkish Society of Haematology | 2016

Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia.

Ali Alkan; Tuğçe Kütük; Ebru Karcı; Arzu Yaşar; Ayşe Hiçsönmez; Güngör Utkan

Tumor lysis syndrome (TLS) is an important oncological emergency that is usually observed with hematological malignancies and rarely with solid tumors. It can be induced either by therapy or spontaneously. Radiotherapy-induced TLS has been rarely reported in the literature. Here we present a patient with a diagnosis of metastatic prostate cancer and chronic lymphocytic leukemia complicated with TLS during palliative radiotherapy.


Supportive Care in Cancer | 2017

Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients

Ali Alkan; Arzu Yaşar; Ebru Karcı; Elif Berna Koksoy; Muslih Ürün; Filiz Çay Şenler; Yuksel Urun; Gülseren Tuncay; Hakan Ergün; Hakan Akbulut


Supportive Care in Cancer | 2016

Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG).

Ali Alkan; Zeynep Gulsum Guc; Filiz Cay Senler; Tugba Yavuzsen; Handan Onur; Mutlu Dogan; Ebru Karcı; Arzu Yaşar; Elif Berna Koksoy; Ozgur Tanriverdi; Serdar Turhal; Yuksel Urun; Asiye Ozkan; Dilsa Mizrak; Hakan Akbulut


Supportive Care in Cancer | 2017

Vaccination in oncology practice and predictors

Ali Alkan; Ebru Karcı; Arzu Yaşar; Gülseren Tuncay; Elif Berna Koksoy; Muslih Ürün; Filiz Çay Şenler; Ahmet Demirkazik; Güngör Utkan; Hakan Akbulut; Yuksel Urun


Annals of Oncology | 2015

Journey to a faraway land

Ali Alkan; Ebru Karcı; Güngör Utkan


Journal of Clinical Oncology | 2018

Independent prognostic value of inflammation in metastatic pancreatic cancer.

Berna Oksuzoglu; Ece Esin; Elif Berna Koksoy; Nebi Serkan Demirci; Mehmet Ali Nahit Sendur; Isa Dede; Ahmet Sezer; Ebru Karcı; Nuriye Yildirim; Bulent Yalcin; Güngör Utkan; Yuksel Urun


Annals of Oncology | 2018

1539OPost-traumatic growth and death anxiety in caregivers of cancer patients: PHOENIX study

Ali Alkan; Elif Berna Koksoy; Ebru Karcı; H Burgaç; A Arıkanoğlu Soğancı; D Yaman; F. Çay Şenler


Annals of Oncology | 2017

1423PLoneliness and cognitive dysfunction in elderly cancer patients

Ali Alkan; H. Selvi Öztorun; Ebru Karcı; Gülseren Tuncay; Arzu Yaşar; Esat Çinar; Yuksel Urun; Sevgi Aras; Murat Varli; F. Çay Şenler

Collaboration


Dive into the Ebru Karcı's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge